FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.7  |  FHIR Version n/a  User: [n/a]

8940801000001103: Re-introduced (qualifier value)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40298601000001113 Re-introduced (qualifier value) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
40298701000001115 Re-introduced en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Re-introduced Is a Non-availability indicator true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Niaspan 500mg modified-release tablets (Merck Pharmaceuticals) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets 7 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clofazimine 100mg capsules 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clofazimine 100mg capsules 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetracosactide 250micrograms/1ml solution for injection ampoules 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lamprene 100mg capsules (Alliance Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Niaspan 500mg modified-release tablets (Mawdsley-Brooks & Company Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Synacthen 250micrograms/1ml solution for injection ampoules (Atnahs Pharma UK Ltd) 5 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Clofazimine 100mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Lamprene 100mg capsules (Alliance Pharmaceuticals Ltd) 100 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Niaspan 500mg modified-release tablets (Merck Pharmaceuticals) 56 tablet 4 x 14 tablets VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Niaspan 500mg modified-release tablets (Mawdsley-Brooks & Company Ltd) 56 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Niaspan 500mg modified-release tablets (Merck Pharmaceuticals) 7 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Nicotinic acid 500mg modified-release tablets (Special Order) 1 tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Synacthen Depot 1mg/1ml suspension for injection ampoules (Atnahs Pharma UK Ltd) 10 ampoule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5mL elixir VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sanomigran 0.25mg/5ml elixir (Novartis Pharmaceuticals UK Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution sugar free (Special Order) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution sugar free 300 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution sugar free 1 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sanomigran 0.25mg/5ml elixir (Novartis Pharmaceuticals UK Ltd) 300 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Pizotifen 250micrograms/5ml oral solution sugar free (Special Order) 1 ml VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (AM Distributions (Yorkshire) Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Sodium alginate 500mg / Potassium bicarbonate 100mg chewable tablets sugar free (AM Distributions (Yorkshire) Ltd) 60 tablet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely doxepin (as doxepin hydrochloride) 10 milligram/1 each conventional release oral capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sinequan 10mg capsules (Pfizer Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules 56 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Sinequan 10mg capsules (Pfizer Ltd) 56 capsule 4 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Doxepin 10mg capsules (Special Order) 1 capsule VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Ennogen Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Ennogen Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Ennogen Pharma Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 1.25mg capsules (Ennogen Pharma Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 2.5mg capsules (Ennogen Pharma Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Ramipril 5mg capsules (Ennogen Pharma Ltd) 28 capsule 2 x 14 capsules VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 10 milligram/1 gram conventional release eye ointment VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely atropine sulfate 5 milligram/1 milliliter conventional release eye drops VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 6% solution for injection 500ml bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Volulyte 6% infusion 500ml bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metformin 1g oral powder sachets sugar free VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 10% infusion 500ml bags VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Voluven 6% solution for injection 500ml bags (Fresenius Kabi Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Venofundin 6% solution for infusion 500ml bags (B.Braun Medical Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 6% solution for injection 500ml bags 15 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucophage 1000mg oral powder sachets (Merck Serono Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Generic Volulyte 6% infusion 500ml bags 15 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 10% infusion 500ml bags 20 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Voluven 10% infusion 500ml Freeflex bags (Fresenius Kabi Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metformin 1g oral powder sachets sugar free (J M McGill Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (A A H Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Volulyte 6% solution for infusion 500ml bags (Fresenius Kabi Ltd) VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Waymade Healthcare Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 6% solution for injection 500ml bags 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Tetrastarch 6% solution for injection 500ml bags 20 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Metformin 1g oral powder sachets sugar free 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Unichem Plc) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metformin 1g oral powder sachets sugar free 60 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Martindale Pharmaceuticals Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Unichem Plc) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Waymade Healthcare Plc) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Metformin 1g oral powder sachets sugar free (J M McGill Ltd) 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Voluven 6% solution for injection 500ml bags (Fresenius Kabi Ltd) 15 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Venofundin 6% solution for infusion 500ml bags (B.Braun Medical Ltd) 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Glucophage 1000mg oral powder sachets (Merck Serono Ltd) 30 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Voluven 6% solution for injection 500ml bags (Fresenius Kabi Ltd) 1 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Volulyte 6% solution for infusion 500ml bags (Fresenius Kabi Ltd) 15 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Voluven 10% infusion 500ml Freeflex bags (Fresenius Kabi Ltd) 20 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Martindale Pharmaceuticals Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Martindale Pharmaceuticals Ltd) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Glucophage 1000mg oral powder sachets (Merck Serono Ltd) 60 sachet VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Special Order) 1 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (A A H Pharmaceuticals Ltd) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (Special Order) 1 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Venofundin 6% solution for infusion 500ml bags (B.Braun Medical Ltd) 20 bag VMP non-availability indicator False Re-introduced Inferred relationship Existential restriction modifier
Atropine 0.5% eye drops (A A H Pharmaceuticals Ltd) 10 ml VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Atropine 1% eye ointment (Unichem Plc) 3 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd) 30 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Calcipotriol 50micrograms/g ointment (Sandoz Ltd) 60 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely amoxapine 100 milligram/1 each conventional release oral tablet VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cefoxitin (as cefoxitin sodium) 1 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely cefoxitin (as cefoxitin sodium) 2 gram/1 vial powder for conventional release solution for injection VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Product containing precisely triamcinolone acetonide 1 milligram/1 gram conventional release oromucosal paste VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Asendis 100mg tablets (Goldshield Healthcare Ltd) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 2g powder for solution for injection vials 5 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste 5 gram VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Cefoxitin 2g powder for solution for injection vials 10 vial VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier
Triamcinolone 0.1% oromucosal paste (Special Order) VMP non-availability indicator True Re-introduced Inferred relationship Existential restriction modifier

Start Previous Page 62 of 86 Next End

This concept is not in any reference sets

Back to Start